Steroid drugs: Anti-inflammatory properties help manage symptoms, particularly in autoimmune-related cholestasis. Farnesoid X receptor agonists: Inhibit bile acid synthesis and promote bile flow, ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved LIVMARLI® (maralixibat) oral solution for ...
Please provide your email address to receive an email when new articles are posted on . Albiero Pharma Inc. announced it received FDA approval for Bylvay to treat pruritus in all subtypes of ...